BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 37114476)

  • 1. Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies.
    Kiran NS; Yashaswini C; Maheshwari R; Bhattacharya S; Prajapati BG
    ACS Pharmacol Transl Sci; 2024 Apr; 7(4):967-990. PubMed ID: 38633600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of PD-L1 expression and pathway-related molecular subtypes in advanced Asian colorectal cancer patients.
    Qiu Q; Tan D; Chen Q; Zhou R; Zhao X; Wen W; Yang P; Li J; Gong Z; Zhang D; Wang M
    Am J Cancer Res; 2024; 14(2):796-808. PubMed ID: 38455414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives.
    Aghabozorgi AS; Bahreyni A; Soleimani A; Bahrami A; Khazaei M; Ferns GA; Avan A; Hassanian SM
    Biochimie; 2019 Feb; 157():64-71. PubMed ID: 30414835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer.
    Peng H; Ying J; Zang J; Lu H; Zhao X; Yang P; Wang X; Li J; Gong Z; Zhang D; Wang Z
    Cancer Res Treat; 2023 Oct; 55(4):1270-1280. PubMed ID: 37114476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2013 Jul; 15(7):517-27. PubMed ID: 23429431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Lynch syndrome, BRAF
    Zwart K; van der Baan FH; Cohen R; Aparicio T; de la Fouchardiére C; Lecomte T; Punt CJA; Sefrioui D; Verheijden RJ; Vink GR; Wensink GE; Zaanan A; Koopman M; Tougeron D; Roodhart JML
    Cancer Med; 2023 Aug; 12(15):15841-15853. PubMed ID: 37326121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
    Wang C; Ouyang C; Cho M; Ji J; Sandhu J; Goel A; Kahn M; Fakih M
    Oncologist; 2021 Mar; 26(3):208-214. PubMed ID: 33230914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer.
    Cen B; Wei J; Wang D; Xiong Y; Shay JW; DuBois RN
    Oncogene; 2021 Oct; 40(41):5984-5992. PubMed ID: 34385594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data.
    Han X; Zhang S; Zhou DC; Wang D; He X; Yuan D; Li R; He J; Duan X; Wendl MC; Ding L; Niu B
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33461213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis.
    Chiavarina B; Costanza B; Ronca R; Blomme A; Rezzola S; Chiodelli P; Giguelay A; Belthier G; Doumont G; Van Simaeys G; Lacroix S; Yokobori T; Erkhem-Ochir B; Balaguer P; Cavailles V; Fabbrizio E; Di Valentin E; Gofflot S; Detry O; Jerusalem G; Goldman S; Delvenne P; Bellahcène A; Pannequin J; Castronovo V; Turtoi A
    Theranostics; 2021; 11(4):1626-1640. PubMed ID: 33408771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer.
    Mondaca S; Walch H; Nandakumar S; Chatila WK; Schultz N; Yaeger R
    Gastroenterology; 2020 Nov; 159(5):1975-1978.e4. PubMed ID: 32730818
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.